AstraZeneca
An Associate Director Scientist at Evinova Endpoints (AstraZeneca Group) focused on advancing digital health and clinical outcome assessments to support drug development. The role centers on generating quantitative evidence and validating novel endpoints using clinical outcomes and wearable data across therapeutic areas such as oncology and cardiometabolic diseases.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Executive Director/Vice President, Biostatistics
Acrivon Therapeutics
Computational Chemist
Ashby
Statistical Scientist, Oncology (Biostatistics)
Astellas
Senior Scientist/Associate Director - Clinical Pharmacology & Quantitative Science
Genmab
Director, Quantitative Pharmacology and Pharmacometrics – Oncology
MSD
Director, Biostatistics
Tango Therapeutics